do not combine glp-1 receptor agonists with dpp-4 inhibitors guideline Frontiers | for treating T2DM Working mechanisms of GLP-1, GLP-1
Description
doi: 10.1038/379069a0 198 TyeK
Similar results were reported in STEP-HFpEF DM, which included patients with diabetes excluded in STEP-HFpEF [30]
wrote the initial draft with H.M.P., E.F., S.L.B., S.D.G., B.M., and D.C.P
doi: 10.1210/jc.2017-02006 25 JonesLABrierleyDI
[DOI] [PubMed] [Google Scholar] 40.Calvarysky B, Dotan I, Shepshelovich D, Leader A, Cohen TD
00174-1/asset/4ff9bb50-3a8f-4946-a683-db1579705072/main.assets/gr1.jpg)
